Wegovy

Wegovy is the brand name for injectable semaglutide manufactured by Novo Nordisk, FDA-approved specifically for chronic weight management in adults (and some adolescents) with obesity or overweight plus a related condition. It shares its active ingredient with Ozempic, which is approved for type 2 diabetes, though Wegovy is typically dosed at a higher maintenance level.